Blood test detects early signs of breast cancer recurrence
Researchers at Lund University have validated a blood-based method for measuring circulating tumor DNA in patients with early breast cancer. The method was able to identify breast cancer patients at high risk of recurrence and detect molecular signs of relapse before the disease became clinically visible using today’s standard methods. Study at a glance: prospective observational study // quantita
https://www.lunduniversity.lu.se/article/blood-test-detects-early-signs-breast-cancer-recurrence - 2026-06-07
